Factors Influencing Resection Time in Endoscopic Submucosal Dissection for Rectal Neuroendocrine Tumors
- PMID: 40909210
- PMCID: PMC12404866
- DOI: 10.1002/deo2.70199
Factors Influencing Resection Time in Endoscopic Submucosal Dissection for Rectal Neuroendocrine Tumors
Abstract
Objectives: The usefulness of endoscopic submucosal dissection (ESD) for rectal neuroendocrine tumors (NETs) is well established. However, factors influencing resection time remain unclear. This study aimed to identify these factors during ESD for rectal NETs.
Methods: This retrospective study included 194 rectal NET lesions that were treated with ESD at our institution between March 2011 and July 2024. Potential factors influencing resection time-including age, sex, operator experience (non-expert endoscopist: <50 colorectal ESD cases), sodium hyaluronate use, traction device (TD) use, tumor location, lesion size, and specimen area-were analyzed using multiple regression analysis.
Results: The median resection time was 30 min (interquartile range [IQR]: 20-43 min). Non-expert endoscopists performed 53% of the procedures. The median specimen area was 302 mm2 (IQR: 233-393 mm2). Resection time was significantly longer when procedures were performed by non-experts (β = 8.66; 95% confidence interval [CI]: 4.46-12.86; p <0.001), when the tumor was located in the upper rectum (Rs) compared to the lower rectum (Rb) (β = 20.96; 95% CI: 7.82-34.1; p = 0.002), and with increasing specimen area (β = 0.04; 95% CI: 0.027-0.06; p <0.001). Conversely, TD use significantly shortened resection time (β = -5.90; 95% CI: -11.37 to -0.43; p = 0.036).
Conclusions: Traction device use during ESD for rectal NETs is associated with shorter resection time; whereas, procedures performed by non-experts, tumors located in the Rs, and larger specimen areas were associated with longer resection time.
Keywords: endoscopic submucosal dissection; neuroendocrine tumor; procedure time; rectum; traction device.
© 2025 The Author(s). DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
The efficacy of endoscopic submucosal dissection for 10-20 mm rectal neuroendocrine tumors based on resection margin status.Surg Endosc. 2025 Sep 8. doi: 10.1007/s00464-025-11984-y. Online ahead of print. Surg Endosc. 2025. PMID: 40921837
-
Endoscopic treatment of rectal neuroendocrine tumors: a consecutive analysis of multi-institutional data.Ann Coloproctol. 2025 Jun;41(3):221-231. doi: 10.3393/ac.2024.00927.0132. Epub 2025 Jun 30. Ann Coloproctol. 2025. PMID: 40598988 Free PMC article.
-
Safety and Efficacy of Simplified EMR Versus ESD for Rectal Neuroendocrine Tumors ≤ 10 Mm: A Retrospective Cohort Study.J Clin Med. 2025 Aug 29;14(17):6125. doi: 10.3390/jcm14176125. J Clin Med. 2025. PMID: 40943884
-
Endoscopic resection therapies for rectal neuroendocrine tumors: a systematic review and meta-analysis.J Gastroenterol Hepatol. 2014 Feb;29(2):259-68. doi: 10.1111/jgh.12395. J Gastroenterol Hepatol. 2014. PMID: 24118068
-
The Impact of Traction Methods on Endoscopic Submucosal Dissection Efficacy for Gastric Neoplasia: A Systematic Review and Meta-analysis.J Gastrointest Cancer. 2024 Mar;55(1):129-142. doi: 10.1007/s12029-023-00982-9. Epub 2023 Nov 13. J Gastrointest Cancer. 2024. PMID: 37953438
References
-
- Gordon J. I. and Hermiston M. L., “Differentiation and Self‐renewal in the Mouse Gastrointestinal Epithelium,” Current Opinion in Cell Biology 6 (1994): 795–803. - PubMed
-
- Yao J. C., Hassan M., Phan A., et al., “One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States,” Journal of Clinical Oncology 26 (2008): 3063–3072. - PubMed
-
- Cho M. Y., Kim J. M., Sohn J. H., et al., “Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP‐NETs) in Korea 2000–2009: Multicenter Study,” Cancer research and treatment: official journal of Korean Cancer Association 44 (2012): 157–165. - PMC - PubMed
-
- Fraenkel M., Kim M., Faggiano A., et al., “Incidence of Gastroenteropancreatic Neuroendocrine Tumours: A Systematic Review of the Literature,” Endocrine‐Related Cancer 21 (2014): R153–R163. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous